CXCL9 and neoplasm: Pre-clinical modeling has shown that tumor-associated eosinophils express chemokines, such as CCL5, CXCL9, and CXCL10, which promote recruitment of tumor reactive CD8+ T cells into the tumor microenvironment [24].